Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on April 14, 2025

David M. Jakubowicz, MD Elected President of the Medical Society of the State of New York (MSSNY)
MSSNY is the State’s Primary Professional Organization for Physicians WESTBURY, NY, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- David M. Jakubowicz, MD was elected President of the Medical Society of the State of New York on April 5. He will be …

Fluoropolymers Recently Diversified at Alfa Chemistry: FEP, PFA, PEEK Are Added
The chemical supplier Alfa Chemistry has expanded its fluoropolymer range to incorporate FEP, Perfluoroalkoxy Alkane (PFA), and Polyetheretherketone (PEEK). NY, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- The chemical supplier Alfa Chemistry …

Become a Surrogate Near Me — Surrogacy4All.com Launches Nationwide Recruitment Campaign
Women across the U.S. and Canada are encouraged to apply to become surrogates with up to $80,000 in reimbursement and full-service support, locally and online NEW YORK, NY, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Surrogacy4All.com, one of …

The Brookbush Institute Publishes NEW Updates: 'Glossary: Stretch Shortening Cycle, Course: Power Training'
The Brookbush Institute continues to enhance education with new courses, a modern glossary, an AI Tutor, and a client program generator. NEW YORK, NY, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Excerpt from the course: Power (High-velocity) …

Dr. Lara Devgan Scientific Beauty RELAUNCHES with Next-Generation Skincare Innovations
The new Scientific Beauty line introduces a range of advanced and updated products with higher concentrations of active ingredients and premium packaging. NEW YORK, NY, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- A REINTRODUCTION Renowned …

Sun Knowledge Inc. Transforms Prior Authorization with Innovative, Cost-Effective Solutions
Sun Knowledge, a leading healthcare outsourcing provider, is revolutionizing prior authorization services with cutting-edge, cost-effective solutions NEW YORK, NY, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Sun Knowledge Inc., a leading …

Majesty Recovery Announces Rebrand and New Supplier Partnerships in the Wellness Space
Rebranded from Royal Massage Chairs, Majesty Recovery expands offerings through strategic partnerships. EAST NORTHPORT, NY, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Majesty Recovery, a premium wellness brand based in New York, is proud to …

NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed “INVO Fertility, Inc.”
Public company to operate under new name and concentrate on building, acquiring and operating fertility clinics and the distribution of FDA-cleared INVOcell device Private company to operate as NAYA Therapeutics and focus on clinical development of …

MediciNova To Participate in D. Boral’s Capital Global Conference on May 14, 2025
LA JOLLA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announces that their CEO, …

Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results
- Appointed John H. Johnson as Executive Chairman; Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer; and Reena Thomas Colacot as Vice President and Head of Quality NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: …

BioSyent to Attend Planet MicroCap Showcase
MISSISSAUGA, Ontario, April 14, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase: VEGAS 2025 investor conference in Las Vegas, Nevada from April 22nd to April …

Cue Biopharma Announces Proposed Public Offering
BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …

Cue Biopharma to Host Business Update Call and Webcast
BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …

Aurora Spine Announces the Resignation of Board Director James Snow
CARLSBAD, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that …

Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases
Partnership bolsters Boehringer’s autoimmune and inflammatory disease pipeline portfolio aiming to tackle areas of high unmet patient need. The agreement focuses on further research and development of a novel, first-in-class bispecific compound for T cell …

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases, today announced that it …

TOMI Environmental Solutions, Inc. Reports Fourth Quarter and Year End 2024 Financial Results
FREDERICK, Md., April 14, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its …

Voting Rights and Shares Capital of the Company
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, April 14, 2025 (GLOBE NEWSWIRE) -- Market: Euronext Paris / Nasdaq …

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 14 avr. 2025 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext Compartiment : B Code ISIN : …

BioStem Technologies Reports Record Preliminary Fourth-Quarter Net Revenue of $102.9 Million and Preliminary Full-Year 2024 Revenue of $301.8 Million
Company reports record preliminary fourth quarter net revenue of $102.9 Million, contributing to a total of $301.8 Million in revenue for 2024 Achieves preliminary GAAP net income of $15.5 million, or $0.94 per share, marking the fourth consecutive quarter …